<DOC>
	<DOCNO>NCT02174068</DOCNO>
	<brief_summary>Pain remain leading cause consultation . Despite wide therapeutic arsenal , significant percentage patient disclaim little pain relief common analgesic , specific type pain . This especially true case chronic pain , current treatment associate many side effect . A need therapeutic innovation need . Paracetamol currently widely use analgesic worldwide despite excellent safety , analgesic effect limit moderate severe pain . Many analgesic drug combination include paracetamol , recently co-administration paracetamol nefopam show supra-additive antinociceptive effect ( Van Elstraete AC et al . 2013 ) . The development formulation associate paracetamol nefopam first require search possible pharmacokinetic interaction two active substance assess safety combination healthy volunteer . No published study provide information .</brief_summary>
	<brief_title>A Pharmacokinetic Drug Interaction Tolerance Study Paracetamol Nefopam</brief_title>
	<detailed_description>This randomise , cross-over , open label trial assess drug interaction paracetamol nefopam healthy volunteer .</detailed_description>
	<mesh_term>Nefopam</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Age 18 ALT , AST , PAL , normal GGT , creatinine &lt; 133Î¼mol / L , hematocrit &gt; 38 % Informed consent trial Healthy volunteer affiliate French Social Security</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Paracetamol</keyword>
	<keyword>Nefopam</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Drug interaction</keyword>
</DOC>